Published in Mol Cell Biol on September 14, 2015
Comparison of Cas9 activators in multiple species. Nat Methods (2016) 0.96
A multi-purpose toolkit to enable advanced genome engineering in plants. Plant Cell (2017) 0.92
Genome Editing by CRISPR/Cas9: A Game Change in the Genetic Manipulation of Protists. J Eukaryot Microbiol (2016) 0.84
A CRISPR Path to Engineering New Genetic Mouse Models for Cardiovascular Research. Arterioscler Thromb Vasc Biol (2016) 0.81
Molecular phenotyping of infection-associated small non-coding RNAs. Philos Trans R Soc Lond B Biol Sci (2016) 0.81
Precision Modulation of Neurodegenerative Disease-Related Gene Expression in Human iPSC-Derived Neurons. Sci Rep (2016) 0.78
tCRISPRi: tunable and reversible, one-step control of gene expression. Sci Rep (2016) 0.75
HIV-1 Integrates Widely throughout the Genome of the Human Blood Fluke Schistosoma mansoni. PLoS Pathog (2016) 0.75
mCAL: A New Approach for Versatile Multiplex Action of Cas9 Using One sgRNA and Loci Flanked by a Programmed Target Sequence. G3 (Bethesda) (2016) 0.75
Genetic and epigenetic control of gene expression by CRISPR-Cas systems. F1000Res (2017) 0.75
Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system. Oncotarget (2016) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
RNA-guided human genome engineering via Cas9. Science (2013) 48.29
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
Silencing of microRNAs in vivo with 'antagomirs'. Nature (2005) 32.56
Origins and Mechanisms of miRNAs and siRNAs. Cell (2009) 20.77
DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol (2013) 19.99
CRISPR/Cas, the immune system of bacteria and archaea. Science (2010) 18.72
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature (2011) 17.38
Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res (2011) 16.53
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A (2012) 16.48
RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol (2013) 15.51
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol (2013) 14.28
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods (2007) 13.94
Development and applications of CRISPR-Cas9 for genome engineering. Cell (2014) 13.50
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell (2013) 13.43
Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol (2011) 12.86
Genome-scale CRISPR-Cas9 knockout screening in human cells. Science (2013) 12.36
CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol (2013) 11.35
Genetic screens in human cells using the CRISPR-Cas9 system. Science (2013) 10.75
The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res (2011) 10.43
Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science (2014) 10.43
CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell (2013) 9.55
Argonaute proteins: key players in RNA silencing. Nat Rev Mol Cell Biol (2008) 8.96
Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics (2013) 8.56
One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell (2013) 7.99
Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res (2013) 7.77
Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA (2004) 7.71
Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol (2014) 7.41
C. elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression. Nat Genet (2003) 7.25
3' UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods (2006) 6.96
Cas9 as a versatile tool for engineering biology. Nat Methods (2013) 6.87
Optical control of mammalian endogenous transcription and epigenetic states. Nature (2013) 6.09
Revealing the world of RNA interference. Nature (2004) 5.92
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature (2014) 5.70
Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci U S A (1998) 5.46
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell (2014) 5.43
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature (2014) 5.19
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol (2014) 5.07
A public genome-scale lentiviral expression library of human ORFs. Nat Methods (2011) 4.98
High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature (2014) 4.95
RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods (2013) 4.85
CRISPR RNA-guided activation of endogenous human genes. Nat Methods (2013) 4.69
hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes. Genomics (2007) 4.62
Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat Biotechnol (2014) 4.16
Positive and negative regulation of endogenous genes by designed transcription factors. Proc Natl Acad Sci U S A (2000) 3.92
Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell (2014) 3.76
Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol (2014) 3.66
Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat Biotechnol (2009) 3.66
Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol (2015) 3.56
A systematic mammalian genetic interaction map reveals pathways underlying ricin susceptibility. Cell (2013) 3.53
Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci U S A (2013) 3.53
Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res (2013) 3.51
Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res (2013) 3.50
Human ORFeome version 1.1: a platform for reverse proteomics. Genome Res (2004) 3.36
Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat Methods (2013) 3.26
Automatic identification of subcellular phenotypes on human cell arrays. Genome Res (2004) 3.25
Robust, synergistic regulation of human gene expression using TALE activators. Nat Methods (2013) 2.89
Off-target effects by siRNA can induce toxic phenotype. RNA (2006) 2.89
Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Res (2012) 2.83
Designing transcription factor architectures for drug discovery. Mol Pharmacol (2004) 2.44
Therapeutic genome editing: prospects and challenges. Nat Med (2015) 2.42
A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell (2014) 2.27
Overcoming transcription activator-like effector (TALE) DNA binding domain sensitivity to cytosine methylation. J Biol Chem (2012) 2.25
Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens. Proc Natl Acad Sci U S A (2014) 2.25
A bioinformatics method identifies prominent off-targeted transcripts in RNAi screens. Nat Methods (2012) 2.13
CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat Protoc (2013) 2.05
STRUCTURAL BIOLOGY. A Cas9-guide RNA complex preorganized for target DNA recognition. Science (2015) 1.82
Highly efficient Cas9-mediated transcriptional programming. Nat Methods (2015) 1.81
Sequence-specific inhibition of microRNA via CRISPR/CRISPRi system. Sci Rep (2014) 1.78
The CRISPR/Cas9 system for plant genome editing and beyond. Biotechnol Adv (2014) 1.64
C911: A bench-level control for sequence specific siRNA off-target effects. PLoS One (2012) 1.32
Gene overexpression: uses, mechanisms, and interpretation. Genetics (2012) 1.31
Zinc-finger-based artificial transcription factors and their applications. Adv Drug Deliv Rev (2009) 1.25
Recognition of methylated DNA by TAL effectors. Cell Res (2012) 1.23
Advances in zinc finger engineering. Curr Opin Struct Biol (2000) 1.11
ULtiMATE system for rapid assembly of customized TAL effectors. PLoS One (2013) 1.10
Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells. Nat Commun (2014) 1.09
Next-generation libraries for robust RNA interference-based genome-wide screens. Proc Natl Acad Sci U S A (2015) 1.08
Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators. Genome Res (2015) 0.92
Systematic analysis of RNAi reports identifies dismal commonality at gene-level and reveals an unprecedented enrichment in pooled shRNA screens. Comb Chem High Throughput Screen (2013) 0.91
Complete decoding of TAL effectors for DNA recognition. Cell Res (2014) 0.85